Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124058 | SCV000167467 | benign | not specified | 2014-04-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000676862 | SCV001041648 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492451 | SCV002801719 | likely benign | Mitochondrial complex 1 deficiency, nuclear type 17; Fanconi renotubular syndrome 5 | 2021-12-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000676862 | SCV004032820 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | NDUFAF6: BP4, BP7 |
Breakthrough Genomics, |
RCV000676862 | SCV005223912 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676862 | SCV000802674 | likely benign | not provided | 2016-02-23 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000676862 | SCV001740886 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000676862 | SCV001968503 | likely benign | not provided | no assertion criteria provided | clinical testing |